A novel lead of P-selectin inhibitor: Discovery, synthesis, bioassays and action mechanism

Bioorg Med Chem Lett. 2016 Oct 1;26(19):4631-4636. doi: 10.1016/j.bmcl.2016.08.061. Epub 2016 Aug 21.

Abstract

By docking 126 derivatives of β-carboline-3-carboxylic acid, tetrahydro-β-carboline-3-carboxylic acid and indoloquinolizine into the active pocket of P-selectin (2-(3-(hydroxymethyl)-9H-pyrido[3,4-b]indol-1-yl)ethyl)-l-phenylalanine (HMCEF) was assigned a novel inhibitor. ELISA and flow cytometry experiments showed that HMCEF effectively down-regulated P-selectin expression and supported the rationality of the computer assistant screening, while UV spectrum experiments demonstrated that HMCEF directly bound to P-selectin. In vivo HMCEF dose dependently inhibited the rats and mice to form thrombus and had a minimal effective dose of 20nmol/kg, dose dependently inhibited inflammatory response of mice and had a minimal effective dose of 20nmol/kg. The decrease of serum TNFα and IL-8 of the treated mice was proposed to be the action mechanism of HMCEF inhibiting thrombosis and inflammation. All data imply that HMCEF is a novel lead of P-selectin inhibitor.

Keywords: Anti-inflammation; Anti-thrombosis; Inhibitor; P-selectin; β-Carboline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Drug Discovery
  • Enzyme-Linked Immunosorbent Assay
  • Indoles / chemical synthesis
  • Indoles / chemistry
  • Indoles / pharmacology*
  • Mice
  • P-Selectin / antagonists & inhibitors*
  • Phenylalanine / analogs & derivatives*
  • Phenylalanine / chemical synthesis
  • Phenylalanine / chemistry
  • Phenylalanine / pharmacology
  • Rats
  • Spectrophotometry, Ultraviolet

Substances

  • 2-(3-(hydroxymethyl)-9H-pyrido(3,4-b)indol-1-yl)ethyl)-l-phenylalanine
  • Indoles
  • P-Selectin
  • Phenylalanine